Not from Advocate Aurora Health? Click the title link for additional options to access full-text. For best viewing, we recommend Google Chrome.

Follow

Works from 2021

Link

Abstract PS7-01: Characteristics and outcomes of SARS-CoV-2 infection in patients with invasive breast cancer (BC) from the COVID-19 and cancer consortium (CCC19) cohort study, Ali Raza Khaki, Dimpy Shah, Michael A. Thompson, et al. (Abstract)

Link

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium, P Grivas, A R Khaki, T M Wise-Draper, et al. (Article)

Link

Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19, Michael A. Thompson, Jeffrey P Henderson, Pankil K Shah, et al. (Article)

Link

Care without a compass: including patients with cancer in COVID-19 studies, Christopher R Friese, Toni K Choueiri, Narjust Duma, et al. (Article)

Link

COVID-19 and cancer: A review of the registry-based pandemic response, Aakash Desai, Turab J Mohammed, Narjust Duma, et al. (Article)

Link

Dosimetric benefits of omitting primary tumor beds in postoperative radiotherapy after transoral robotic surgery using the auto-planning technique, Taoran Cui, Matthew C. Ward, Jeffrey A. Kittel, et al. (Article)

Link

ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation, Shaji Kumar, Zihan Wei, Michael A. Thompson, et al. (Abstract)

Link

Identification of potential germline (GL) variants by routine clinical comprehensive genomic profiling (CGP) and confirmatory GL testing in 24 tumor types, Kristen Hanson, Michael P. Mullane MD, Deborah Wham, et al. (Abstract)

Link

Impact of the COVID-19 pandemic on oncologist burnout, emotional well-being, and moral distress: Considerations for the cancer organization's response for readiness, mitigation, and resilience, Fay J Hlubocky, Banu E Symington, Daniel C McFarland, et al. (Article)

Link

Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma, Roman Hájek, Jiří Minařík, Jan Straub, et al. (Article)

Link

Modernizing clinical trial eligibility criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group, Alexander I Spira, Mark D Stewart, Suzanne Jones, et al. (Article)

Link

MPN-390: Study design and objectives for a new cohort of patients with myelofibrosis (MF) enrolled in the ongoing Connect® Myeloid Disease Registry, John Mascarenhas, Michael Savona, Michael A. Thompson, et al. (Abstract)

Link

Myocarditis as a rare, yet serious adverse event associated with immune checkpoint inhibitors in patients with non-small cell lung cancer: Case series from a large community-based cancer center, Mohamed Hendawi, Luke Peterson, Eyob Tadesse, et al. (Abstract)

Link

Oncofetal chondroitin sulfate is a highly expressed therapeutic target in non-small cell lung cancer, Htoo Zarni Oo, Zoltan Lohinai, Nastaran Khazamipour, et al. (Article)

Link

P10.03 Pembrolizumab with or without chemotherapy for advanced lung cancer: A real-world analysis of key prognostic factors, S Gadgeel, Mohamed Hendawi, James Weese, et al. (Abstract)

Link

P10.04 Immunotherapy-treated non-small cell lung cancer patients with sensitizing gene alterations: A real world survival analysis, L Khaddour, Eyob Tadesse, Michael A. Thompson, et al. (Abstract)

Link

People with cancer are likely to accept the covid-19 vaccine, but politics tracks with attitudes: An inspire and cosmo survey, Don Dizon, Kathleen Hoffman, Michael A. Thompson, et al. (Abstract)

PDF

Prognostic Implications of Vitamin D in Patients With a Hematologic Malignancy at a Large Health System in Wisconsin, Daniel Mundt, Marianne Klumph, Kayla Heslin, and Michael A. Thompson (Poster)

Link

Pulmonary open, robotic and thoracoscopic lobectomy (PORTaL) study: An analysis of 5,721 cases, Michael S Kent, Matthew G Hartwig, Eric Vallières, et al. (Article)

Link

Rapid real-world data analysis of patients with cancer, with and without COVID-19, across distinct health systems, Clara Hwang, Monika A Izano, Michael A. Thompson, et al. (Article)

Link

Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US, Faith Davies, Robert Rifkin, Caitlin Costello, et al. (Article)

Link

Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes, Jay L Patel, Mehrdad Abedi, Christopher R Cogle, et al. (Article)

Link

Real-world performance of a comprehensive genomic profiling test optimized for small tumor samples, Scott A. Tomlins, Daniel H. Hovelson, Jennifer M. Suga, et al. (Article)

Link

Recommendations to streamline and standardize clinical trial site feasibility assessments: An ASCO research statement, Dax Kurbegov, Patricia Hurley, David M Waterhouse, et al. (Article)

Link

Reduced blood product utilization via implementation of an anemia clinic and consult service in a large health system hospital, Reid Christian Bowers, Sandra Tomany Korman, Michael A. Thompson, et al. (Abstract)

PDF

Refining a Postpandemic Approach to Cancer Screening, Michael A. Thompson (From the Editor)

Link

The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19, Ang Li, Nicole M Kuderer, Chih-Yuan Hsu, et al. (Article)

Link

Use of convalescent plasma in COVID-19 patients with immunosuppression, Jonathon W Senefeld, Stephen A Klassen, Shane K Ford, et al. (Article)

Works from 2020

Link

Association of circulating tumor DNA and circulating tumor cells after neoadjuvant chemotherapy with disease recurrence in patients with triple-negative breast cancer: Preplanned secondary analysis of the BRE12-158 randomized clinical trial, Milan Radovich, Guanglong Jiang, Bradley A Hancock, et al. (Article)

Link

A systematic framework to rapidly obtain data on patients with cancer and COVID-19: CCC19 governance, protocol, and quality assurance, M Abidi, DM Aboulafia, Michael A. Thompson, et al. (Article)

Link

Caplacizumab for treatment of thrombotic thrombocytopenic purpura in a patient with anaphylaxis to fresh-frozen plasma, Mehraboon S. Irani, Federico Sanchez, and Kenneth Friedman (Article)

Link

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study, Nicole M Kuderer, Toni K Choueiri, Dimpy P Shah, et al. (Article)

Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19), Jeremy L Warner, Sam Rubinstein, and Michael A. Thompson (Abstract)

Link

Comparing survival outcomes for neoadjuvant therapy versus adjuvant therapy in the management of stage 1 pancreatic adenocarcinoma: A National Cancer Database study, Samit K. Datta, Geoffrey Bellini, Maharaj Singh, et al. (Abstract)

Comprehensive genomic profiling of 30,000 consecutive solid tumors, Michael Thompson (Article)

PDF

Concordant genomic vulnerabilities of patient-derived cell line and matched xenograft-derived cell line through whole exome sequencing in breast-brain metastatic cancer, Jun Yin, Aspen T. Duffin, Kate Dennert, et al. (Article)

Link

Crowdsourcing a crisis response for COVID-19 in oncology, Aakash Desai, Jeremy Warner, Nicole Kuderer, et al. (Article)

Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect® MDS/AML Disease Registry, Daniel A. Pollyea, Tracy I. George, Michael A. Thompson, et al. (Article)

HealthTree Patient Portal mediated myeloma patient-reported vaccination and antibiotic use, Michael A. Thompson, Jenny Ahlstrom, and Nathan W. Sweeney (Abstract)

PDF

Impact on patient outcomes of creating a robotic complex pancreatic surgery training program, Nicholas Sich, Geoffrey Bellini, James Weese, et al. (Poster)

Link

Incidence of and risk factors for venous thromboembolism among hospitalized patients with cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry, Ang Li, Nicole M Kuderer, Jeremy L. Warner, et al. (Abstract)

Link

LBA72 Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19), P Grivas, J Warner, Michael A. Thompson, et al. (Abstract)

Link

Molecular alterations with hyperprogression in lung cancer patients treated with immune checkpoint inhibitors in a large health system, Eyob Tadesse, Kayla Heslin, Mohamed Hendawi, et al. (Abstract)

Link

Multiple myeloma (MM) vaccination (influenza, FV and pneumococcal, PV) rates worldwide and impact on infection, hospitalization, and death, Michael A. Thompson, Caitlin Costello, and et al (Abstract)

PDF

Oncologic outcomes of robotic compared to open pancreatic surgery: A National Cancer Database participant user file study, Geoffrey Bellini, Maharaj Singh, James Weese, et al. (Poster)

PDF

Oncology precision medicine for hepatobiliary and pancreatic cancer: Insights and updates from a large community health system, Geoffrey Bellini, Nicholas Sich, Jennifer Godden, et al. (Poster)

Link

Oncology precision medicine for hepatobiliary and pancreatic cancer: Insights and updates from a large community health system, Geoffrey Bellini, Nicholas Sich, Jennifer Godden, et al. (Abstract)

Oncology precision medicine for hepatobiliary and pancreatic cancer: Insights and updates upon an institutional review, Geoffrey Bellini, Nicholas Sich, Jennifer Godden, et al. (Abstract)

Link

Phase II trial of carfilzomib plus irinotecan in patients with small-cell lung cancer who have progressed on prior platinum-based chemotherapy, Susanne M Arnold, Kari Chansky, Maria Q Baggstrom, et al. (Article)

Link

Post-remission treatment (Tx) patterns for patients (Pts) with newly diagnosed (ND) acute myeloid leukemia (AML) in the Connect® MDS/AML Disease Registry, Gail J. Roboz, Michael A. Thompson, and et al (Abstract)

Link

Real world observational study using Clonoseq® next generation sequencing in hematologic malignancies: The 'Watch' Registry, Krish Patel, Neil Bailey, Michael A. Thompson, et al. (Abstract)

Link

Reduced blood product utilization via implementation of an anemia clinic and consult service in a large health system hospital, Reid Christian Bowers, Michael A. Thompson, Sandra Tomany Korman, et al. (Abstract)

Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis, T M. Wise-Draper, A Desai, Michael A. Thompson, et al. (Article)

Link

Transplant referral patterns for patients (pts) with newly diagnosed (ND) higher-risk (HR) myelodysplastic dyndromes (MDS), and European leukemianet (ELN) 2010 intermediate-tisk (IR) or adverse-risk (AR) acute myeloid leukemia (AML) in the Connect® MDS/AML registry, Benjamin Tomlinson, Marcos de Lima, Christopher R. Cogle, et al. (Abstract)

Link

Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study, Donna R Rivera, Solange Peters, Orestis A Panagiotou, et al. (Article)

Link

Waging war on war metaphors in cancer and COVID-19, Jonathan M Marron, Don S Dizon, Banu Symington, et al. (Article)

Works from 2019

PDF

Coordinating an Oncology Precision Medicine Clinic Within an Integrated Health System: Lessons Learned in Year One, Michael A. Thompson, Jennifer J. Godden, Deborah Wham, Antony Ruggeri, Michael P. Mullane, Amanda Wilson, Shamsuddin Virani, Scott M. Weissman, Brenda Ramczyk, Pamela Vanderwall, and James L. Weese (Review)

Determining value of a precision medicine program in a vertically integrated healthcare system, James Weese, Michael A. Thompson, and Jennifer Godden (Oral/Podium Presentation)

Link

Mo1412 – Oncologic outcomes of robotic compared to open pancreatic surgery: A national cancer database participant user file study, Geoffrey Bellini, Maharaj Singh, James Weese, et al. (Abstract)

Link

p16 as a biomarker to distinguish atypical ductal hyperplasia from ductal carcinoma in situ and to predict breast cancer progression, Judy A. Tjoe, Brittany S. Last, and Jun Yin (Abstract)

Link

Physiological and psychosocial effects of a highly structured exercise program on breast cancer survivorship, Judy A. Tjoe, Linda B Piacentine, Jun Yin, et al. (Abstract)

Link

Use of treatment pathways reduce cost and decrease ED utilization and unplanned hospital admissions in patients (pts) with stage II breast cancer, James Weese, Corey J. Shamah, Federico A. Sanchez, et al. (Abstract)